Amgen (AMGN) R&D In Process (2021)

Historic R&D In Process for Amgen (AMGN) over the last 1 years, with Q2 2021 value amounting to $1.5 billion.

Amgen's R&D In Process changed N/A to $1.5 billion in Q2 2021 from the same period last year, while for Jun 2022 it was $1.5 billion, marking a year-over-year change of 0.0%. This contributed to the annual value of $1.5 billion for FY2021, which is N/A changed from last year.
As of Q2 2021, Amgen's R&D In Process stood at $1.5 billion.
In the past 5 years, Amgen's R&D In Process ranged from a high of $1.5 billion in Q2 2021 and a low of $1.5 billion during Q2 2021

Peer Comparison